226 related articles for article (PubMed ID: 18646609)
1. [High-titer idiopathic acquired factor V inhibitor patient showing decreased activities of multiple coagulation factors].
Shimizu I; Ichikawa N; Yotsumoto M; Sumi M; Ueno M; Kobayashi H
Rinsho Ketsueki; 2008 Jun; 49(6):413-6. PubMed ID: 18646609
[TBL] [Abstract][Full Text] [Related]
2. [Acquired inhibitor against coagulation factor V with severe hematuria].
Hasegawa M; Tanaka T; Kii T; Fujiwara S; Ikeda N; Kinntaka D; Takeuti T; Tanaka H; Ikemoto T
Rinsho Ketsueki; 2003 Sep; 44(9):933-9. PubMed ID: 14577313
[TBL] [Abstract][Full Text] [Related]
3. Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency.
Ashizawa M; Kimura S; Wada H; Sakamoto K; Sato M; Terasako K; Kikuchi M; Nakasone H; Okuda S; Kako S; Yamazaki R; Oshima K; Matsuura K; Ohmori T; Madoiwa S; Nishida J; Mimuro J; Tabei K; Sakata Y; Kanda Y
Hematology; 2013 Sep; 18(5):300-4. PubMed ID: 23683688
[TBL] [Abstract][Full Text] [Related]
4. [Clinical cases of acquired coagulation inhibitors].
Yamane T; Hino M; Ota K; Akahori M; Hirai M; Inoue T; Mugitani A; Tatsumi N
Rinsho Byori; 2000 Dec; 48(12):1093-101. PubMed ID: 11215417
[TBL] [Abstract][Full Text] [Related]
5. [A long-lasting idiopathic factor V inhibitor].
Okoshi Y; Akiyama H; Inoue T; Koyama T; Kono N; Matsumura T; Mizuchi D; Mori S; Ohashi K; Sakamaki H
Rinsho Ketsueki; 2003 Jan; 44(1):14-8. PubMed ID: 12649832
[TBL] [Abstract][Full Text] [Related]
6. Successful management of a possible antibiotic-related acquired factor V inhibitor: a case report and review of the literature.
Motwani P; Howard L; Ali SS
Acta Haematol; 2013; 129(3):182-4. PubMed ID: 23257771
[TBL] [Abstract][Full Text] [Related]
7. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
8. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors.
Nakata K; Ueda S; Matsunaga H; Mima F; Ueda H; Yoshioka A; Kaneko S; Maruo K; Morris S; Yonemoto S; Hayashi D; Fujii N; Narahara H; Inui Y; Kawata S
Intern Med; 2018 Feb; 57(3):393-397. PubMed ID: 29093398
[TBL] [Abstract][Full Text] [Related]
9. A high titer of acquired factor V inhibitor in a hemodialysis patient who developed arterial thrombosis.
Ogawa H; Souri M; Kanouchi K; Osaki T; Ohkubo R; Kawanishi T; Wakai S; Morikane K; Ichinose A
Int J Hematol; 2019 Feb; 109(2):214-220. PubMed ID: 30446942
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of bleeding in acquired factor V inhibitor: a summary of 33 cases.
Wiwanitkit V
Clin Appl Thromb Hemost; 2006 Oct; 12(4):485-8. PubMed ID: 17000894
[TBL] [Abstract][Full Text] [Related]
11. Acquired Factor V Inhibitor with Hemorrhagic Symptoms after Prasugrel Hydrochloride Treatment.
Sakatoku K; Takakuwa T; Miura A; Araki T; Fujitani Y; Yamamura R
Acta Haematol; 2020; 143(5):478-480. PubMed ID: 31522179
[TBL] [Abstract][Full Text] [Related]
12. Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.
Li F; Shu K; Liu J; Shen C; Wang X; Zhang Z; Jiang M
Acta Haematol; 2019; 141(3):148-150. PubMed ID: 30783058
[No Abstract] [Full Text] [Related]
13. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
[TBL] [Abstract][Full Text] [Related]
14. [Acquired factor V inhibitor: 3 cases report and literature review].
Yang YH; Wang HM; Xue F; Liu XF; Liu YZ; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):294-8. PubMed ID: 22781721
[TBL] [Abstract][Full Text] [Related]
15. A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors.
Kadohira Y; Yamada S; Hayashi T; Morishita E; Asakura H; Ichinose A
Int J Hematol; 2018 Aug; 108(2):145-150. PubMed ID: 29611057
[TBL] [Abstract][Full Text] [Related]
16. A case report of an acquired inhibitor to coagulation factor V.
Shanmugam H; Jayaranee S; Eow GI
Haemophilia; 2011 Jan; 17(1):168-70. PubMed ID: 20557356
[No Abstract] [Full Text] [Related]
17. [Factor V inhibitor with double cancer].
Okajima A; Horii J; Nasu K; Niki Y; Akasaka K; Yamashita H; Sugimoto M; Yoshioka A
Rinsho Ketsueki; 1989 Apr; 30(4):514-9. PubMed ID: 2769972
[TBL] [Abstract][Full Text] [Related]
18. An acquired factor V inhibitor: clinical and laboratory features.
Shastri KA; Ho C; Logue G
J Med; 1999; 30(5-6):357-66. PubMed ID: 10851568
[TBL] [Abstract][Full Text] [Related]
19. [Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics].
Kinjo Y; Yoshimura K; Suzuki T; Shinozawa K; Nakasone K; Yoshimata T; Nishihira M; Henzan E
Rinsho Ketsueki; 2014 Nov; 55(11):2311-5. PubMed ID: 25501413
[TBL] [Abstract][Full Text] [Related]
20. [Anesthetic management of a patient with acquired factor V inhibitor].
Nakamura T; Otsuji M; Kurita A; Yamada K; Tsubokawa T; Yamamoto K
Masui; 2010 Nov; 59(11):1423-7. PubMed ID: 21077315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
